Copyright: ©Author(s) 2026.
Figure 1 Patient selection flowchart.
uHCC: Unresectable hepatocellular carcinoma; ICIs: Immune checkpoint inhibitors; TKIs: Tyrosine kinase inhibitors; VEGF: Vascular endothelial growth factor.
- Citation: Xu C, Liang QY, Sun JP, Zhou K, Pan J, Zhao HT. Radiologic partial response poorly predicts pathologic complete response in hepatocellular carcinoma after conversion therapy. World J Hepatol 2026; 18(9): 123924
- URL: https://www.wjgnet.com/1948-5182/full/v18/i9/123924.htm
- DOI: https://dx.doi.org/10.4254/wjh.123924